摘要
内镜减重作为一种有效的肥胖治疗手段,减重原理类似于减重代谢手术,可分为食物限制型(干预胃)和吸收障碍型(干预肠)。目前,部分内镜减重设备已获得美国食品药品监督管理局批准,而我国在内镜减重领域总体落后于西方国家。现就当下开展干预胃的内镜减重的研究情况做一归纳,旨在为我国肥胖的治疗选择和内镜减重的发展提供参考。
Endoscopic bariatric treatment(EBT)is an effective method for the treatment of obesity.The principle of weight loss is similar to metabolic bariatric surgery.It can be classified as a food restriction(stomach-targeted)and malabsorption(small intestine-targeted).At present,a lot of EBT devices had been cleared by the US Food and Drug Administration to treat obesity,while the EBT in China lagged behind Western countries.Hence,we reviewed the current stomach-targeted EBT,aiming to provide a reference for the supplement of obesity treatment methods and the development of EBT in China.
作者
卞景愿
朱宝成
严斌
王存川
彭志勇
BIAN Jingyuan;ZHU Baocheng;YAN Bin;WANG Cunchuan;PENG Zhiyong(Department of General Surgery,The Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University,Shanghai 201700,P.R.China;Endoscopy Center,The Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University,Shanghai 201700,P.R.China;Weight Loss Center,The First Affiliated Hospital of Jinan University,Guangzhou 510630,P.R.China)
出处
《中国普外基础与临床杂志》
CAS
2024年第4期403-408,共6页
Chinese Journal of Bases and Clinics In General Surgery
基金
上海市青浦区卫生健康委员会基金项目(项目编号:QWJ2022-08)。
关键词
肥胖症
内镜减重
代谢性疾病
胃
obesity
endoscopic bariatric
metabolic diseases
stomach
